Agency Forms Undergoing Paperwork Reduction Act Review, 14120-14121 [2021-05118]
Download as PDF
<![CDATA[
14120
Federal Register / Vol. 86, No. 47 / Friday, March 12, 2021 / Notices
• Seven data elements were added to
the medical record abstraction data
elements to collect information on
SARS–CoV–2 (COVID–19) testing.
Because the medical records are
abstracted by MMP staff, these changes
do not affect the burden of the project.
This proposed data collection would
supplement the National HIV
Surveillance System (NHSS, OMB
Control No. 0920–0573, Exp. 11/30/
2022) in 23 selected state and local
health departments, which collect
information on persons diagnosed with,
living with, and dying from HIV
infection and AIDS. The participation of
respondents is voluntary. There is no
cost to the respondents other than their
time. Through their participation,
respondents will help to improve
programs to prevent HIV infection as
well as services for those who already
have HIV. Total estimated annual
burden requested is 5,707 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average hours
per response
Total response
burden
(hours)
7,760
1
45/60
5,173
Look up contact information .............
1,940
1
2/60
65
Approach persons for enrollment .....
970
1
5/60
81
Pull medical records .........................
7,760
1
3/60
388
...........................................................
........................
........................
........................
5,707
Number of
respondents
Type of respondent
Form name
Sampled, Eligible HIV-Infected Persons.
Facility office staff looking up contact
information.
Facility office staff approaching sampled persons for enrollment.
Facility office staff pulling medical
records.
Interview Questionnaire (Att. 5a) .....
Total ...........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–05120 Filed 3–11–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–0199]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Import Permit
Applications (42 CFR 71.54) to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on October 21, 2020 to obtain
comments from the public and affected
agencies. CDC received one comment
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
VerDate Sep<11>2014
17:04 Mar 11, 2021
Jkt 253001
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
comments within 30 days of notice
publication.
Proposed Project
Import Permit Applications (42 CFR
71.54) (OMB Control No. 0920–0199,
Exp. 04/30/2021)—Revision—Center for
Preparedness and Response (CPR),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Section 361 of the Public Health
Service Act (42 U.S.C. 264), as
amended, authorizes the Secretary of
Health and Human Services to make
and enforce such regulations as are
necessary to prevent the introduction,
transmission, or spread of
communicable diseases from foreign
countries into the States or possessions,
or from one State or possession into any
other State or possession. Part 71 of
Title 42, Code of Federal Regulations
(Foreign Quarantine) sets forth
provisions to prevent the introduction,
transmission, and spread of
communicable disease from foreign
countries into the United States.
Subpart F—Importations—contains
provisions for the importation of
infectious biological agents, infectious
substances, and vectors (42 CFR 71.54);
requiring persons that import these
materials to obtain a permit issued by
the CDC.
The Application for Permit to Import
Biological Agents, Infectious Substances
and Vectors of Human Disease into the
United States form is used by laboratory
facilities, such as those operated by
government agencies, universities, and
E:\FR\FM\12MRN1.SGM
12MRN1
14121
Federal Register / Vol. 86, No. 47 / Friday, March 12, 2021 / Notices
importation, and any subsequent
distribution after importation, of live
bats. This form currently requests the
applicant and sender contact
information; a description and intended
use of bats to be imported; and facility
isolation and containment information.
CDC does not plan to revise this
application.
The Application for Permit to Import
Infectious Human Remains into the
United States is used by facilities that
will bury/cremate the imported cadaver
and educational facilities to request a
permit for the importation and
subsequent transfers throughout the
U.S. of human remains or body parts
that contains biological agents,
infectious substances, or vectors of
human disease. This form will request
applicant and sender contact
information; facility processing human
remains; cause of death; biosafety and
containment information; and final
destination(s) of imported infectious
human remains. CDC does not plan to
revise this application.
Due to the implementation of eIPP
and the applicants ability to complete
the applications on-line without the
need of the guidance document, the
‘‘Guidance Document for Completing
Application for Permit to Import
Biological Agents, Infectious Substances
and Vectors of Human Disease into the
United States’’ is no longer needed. As
such, the total burden hours of 333 for
applicants to review this document was
reduced and this entry was removed
from the burden table.
research institutions to request a permit
for the importation of biological agents,
infectious substances, or vectors of
human disease. This form currently
requests applicant and sender contact
information; description of material for
importation; facility isolation and
containment information; and personnel
qualifications. CDC plans to revise this
application to:
(1) Remove question 10 ‘‘Will the
permittee be the courier of the imported
biological agent?’’ from Section A since
it is the same question found in Section
C, Question 1.
(2) Add example to Section F,
Question 2 for clarity to read,
‘‘Protective Clothing (e.g., laboratory
coat).’’
These revisions will not affect the
burden hours.
CDC received one comment regarding
this notice. The commenter requested
that the contact information for the
biosafety officer field be mandatory. The
commenter also requested that
communications regarding the permit
application be sent to the biosafety
officer and permittee. CDC made no
changes based on these comments as
these recommendations did not request
changes to the form but requested
changes on how the program processes
the application.
The Application for Permit to Import
or Transport Live Bats form is used by
laboratory facilities such as those
operated by government agencies,
universities, research institutions, and
for educational, exhibition, or scientific
purposes to request a permit for the
The Application Requesting to Import
Live Bats is used by laboratory facilities
such as those operated by government
agencies, universities, research
institutions, and for educational,
exhibition, or scientific purposes to
request a permit for the importation of
bats. Based on information from eIPP,
IPP receives three ‘‘Application
Requesting to Import Live Bats’’
requests per year. It takes applicants 20
minutes to complete the application.
The number of applicants was reduced
from ten to three to accurately reflect
the requests received. As such this
change, the total burden hours from
three to one.
Due to the implementation of eIPP
and the applicants’ ability to complete
the applications on-line without the
need of the guidance document, the
‘‘Guidance Document for Completing
Application Requesting to Import Live
Bats’’ is no longer needed. As such, the
total of two burden hours for applicants
to review this document was reduced
and this entry was removed from the
burden table.
Annualized burden hours were
calculated based on data obtained from
CDC import permit database on the
number of permits issued on annual
basis since 2015, which is 2,000
respondents. Due to the implementation
of eIPP in 2020 which increased
response efficiency and the applicants’
ability to complete the applications online without the need of the guidance
documents, the burden hours were
reduced. Total response burden
decreased from 1355 hours to 764 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Applicants Requesting to Import Biological Agents, Infectious Substances and Vectors.
Application for Permit to Import Biological Agents, Infectious Substances and Vectors of Human Disease
into the United States (42 CFR 71.54).
Application for Permit to Import Biological Agents, Infectious Substances and Vectors of Human Disease
into the United States (42 CFR 71.54)—Subsequent
Transfers.
Application for a Permit to Import Live Bats (42 CFR
71.54).
Application for Permit to Import Infectious Human Remains into the United States (42 CFR 71.54).
Applicants Requesting to Import Biological Agents, Infectious Substances and Vectors.
Applicants Requesting to Import Live Bats .....................
Applicants Requesting to Import Infectious Human Remains into the United States.
1
20/60
380
1
10/60
3
1
20/60
100
1
20/60
[FR Doc. 2021–05118 Filed 3–11–21; 8:45 am]
BILLING CODE 4163–18–P
17:04 Mar 11, 2021
Jkt 253001
PO 00000
Frm 00053
Fmt 4703
Sfmt 9990
E:\FR\FM\12MRN1.SGM
Average
burden per
response
(in hours)
2000
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
VerDate Sep<11>2014
Number of
responses per
respondent
Number of
respondents
Type of respondents
12MRN1
]]>Agencies
[Federal Register Volume 86, Number 47 (Friday, March 12, 2021)]
[Notices]
[Pages 14120-14121]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-05118]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-21-0199]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Import Permit Applications (42 CFR 71.54) to
the Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on October 21, 2020 to obtain
comments from the public and affected agencies. CDC received one
comment related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Import Permit Applications (42 CFR 71.54) (OMB Control No. 0920-
0199, Exp. 04/30/2021)--Revision--Center for Preparedness and Response
(CPR), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Section 361 of the Public Health Service Act (42 U.S.C. 264), as
amended, authorizes the Secretary of Health and Human Services to make
and enforce such regulations as are necessary to prevent the
introduction, transmission, or spread of communicable diseases from
foreign countries into the States or possessions, or from one State or
possession into any other State or possession. Part 71 of Title 42,
Code of Federal Regulations (Foreign Quarantine) sets forth provisions
to prevent the introduction, transmission, and spread of communicable
disease from foreign countries into the United States. Subpart F--
Importations--contains provisions for the importation of infectious
biological agents, infectious substances, and vectors (42 CFR 71.54);
requiring persons that import these materials to obtain a permit issued
by the CDC.
The Application for Permit to Import Biological Agents, Infectious
Substances and Vectors of Human Disease into the United States form is
used by laboratory facilities, such as those operated by government
agencies, universities, and
[[Page 14121]]
research institutions to request a permit for the importation of
biological agents, infectious substances, or vectors of human disease.
This form currently requests applicant and sender contact information;
description of material for importation; facility isolation and
containment information; and personnel qualifications. CDC plans to
revise this application to:
(1) Remove question 10 ``Will the permittee be the courier of the
imported biological agent?'' from Section A since it is the same
question found in Section C, Question 1.
(2) Add example to Section F, Question 2 for clarity to read,
``Protective Clothing (e.g., laboratory coat).''
These revisions will not affect the burden hours.
CDC received one comment regarding this notice. The commenter
requested that the contact information for the biosafety officer field
be mandatory. The commenter also requested that communications
regarding the permit application be sent to the biosafety officer and
permittee. CDC made no changes based on these comments as these
recommendations did not request changes to the form but requested
changes on how the program processes the application.
The Application for Permit to Import or Transport Live Bats form is
used by laboratory facilities such as those operated by government
agencies, universities, research institutions, and for educational,
exhibition, or scientific purposes to request a permit for the
importation, and any subsequent distribution after importation, of live
bats. This form currently requests the applicant and sender contact
information; a description and intended use of bats to be imported; and
facility isolation and containment information. CDC does not plan to
revise this application.
The Application for Permit to Import Infectious Human Remains into
the United States is used by facilities that will bury/cremate the
imported cadaver and educational facilities to request a permit for the
importation and subsequent transfers throughout the U.S. of human
remains or body parts that contains biological agents, infectious
substances, or vectors of human disease. This form will request
applicant and sender contact information; facility processing human
remains; cause of death; biosafety and containment information; and
final destination(s) of imported infectious human remains. CDC does not
plan to revise this application.
Due to the implementation of eIPP and the applicants ability to
complete the applications on-line without the need of the guidance
document, the ``Guidance Document for Completing Application for Permit
to Import Biological Agents, Infectious Substances and Vectors of Human
Disease into the United States'' is no longer needed. As such, the
total burden hours of 333 for applicants to review this document was
reduced and this entry was removed from the burden table.
The Application Requesting to Import Live Bats is used by
laboratory facilities such as those operated by government agencies,
universities, research institutions, and for educational, exhibition,
or scientific purposes to request a permit for the importation of bats.
Based on information from eIPP, IPP receives three ``Application
Requesting to Import Live Bats'' requests per year. It takes applicants
20 minutes to complete the application. The number of applicants was
reduced from ten to three to accurately reflect the requests received.
As such this change, the total burden hours from three to one.
Due to the implementation of eIPP and the applicants' ability to
complete the applications on-line without the need of the guidance
document, the ``Guidance Document for Completing Application Requesting
to Import Live Bats'' is no longer needed. As such, the total of two
burden hours for applicants to review this document was reduced and
this entry was removed from the burden table.
Annualized burden hours were calculated based on data obtained from
CDC import permit database on the number of permits issued on annual
basis since 2015, which is 2,000 respondents. Due to the implementation
of eIPP in 2020 which increased response efficiency and the applicants'
ability to complete the applications on-line without the need of the
guidance documents, the burden hours were reduced. Total response
burden decreased from 1355 hours to 764 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Applicants Requesting to Import Application for Permit 2000 1 20/60
Biological Agents, Infectious to Import Biological
Substances and Vectors. Agents, Infectious
Substances and Vectors
of Human Disease into
the United States (42
CFR 71.54).
Applicants Requesting to Import Application for Permit 380 1 10/60
Biological Agents, Infectious to Import Biological
Substances and Vectors. Agents, Infectious
Substances and Vectors
of Human Disease into
the United States (42
CFR 71.54)--Subsequent
Transfers.
Applicants Requesting to Import Live Application for a Permit 3 1 20/60
Bats. to Import Live Bats (42
CFR 71.54).
Applicants Requesting to Import Application for Permit 100 1 20/60
Infectious Human Remains into the to Import Infectious
United States. Human Remains into the
United States (42 CFR
71.54).
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-05118 Filed 3-11-21; 8:45 am]
BILLING CODE 4163-18-P
